In vivo mosquito model with robust, high-amplitude behavioral markers of circadian phase. Uses LAM25 activity monitors to quantify flight activity and host-seeking rhythms in mosquitoes, enabling drug screening, jet lag studies, and circadian clock research with translational relevance to human biology.
This offering provides a specialized in vivo research platform that uses mosquitoes as a model organism for circadian rhythm studies. Unlike Drosophila, many mosquito species exhibit highly concentrated behavioral rhythms, with locomotor activity and host-seeking responses sharply confined to discrete wake and rest phases. The onset of nightly activity is characterized by a rapid transition from prolonged quiescence to intense activity, producing a high-amplitude, well-defined, and readily quantifiable marker of circadian phase.
The platform is particularly relevant for chronobiology research because the most studied mosquito species, Anopheles gambiae, possesses both Drosophila-like and mammalian-like circadian photoreceptors and transcriptional regulators, making its clock mechanisms more comparable to human circadian biology than those of standard fly models. Applications include drug and compound screening, jet lag and phase-shift studies, sleep research, and investigation of circadian disruption effects relevant to disease prevention.
Behavioral monitoring system:
Model organism advantages:
Established experimental protocols:
Scalability:
The platform builds on validated methodologies with a documented history of use in published circadian research. The LAM25 monitoring system, compound delivery via sugar meal, microinjection protocols, and molecular clock gene readouts have all been demonstrated in prior studies. Future validation efforts would include toxicity and dose determination for candidate compounds, followed by automated multi-day observation in LAM behavioral monitors with concurrent perturbation treatments such as jet lag protocols. Data analysis pipelines are established for phase markers, phase-shifts, activity-bout analysis, and acrophase determination. The platform is positioned to support pilot studies, sponsored research collaborations, and co-development of circadian-focused screening assays.
The University of Notre Dame is a private, comprehensive research university with global reach and a residential campus in Notre Dame, Indiana. Industry engages on campus and nearby through a research and technology park, an incubator, and shared core labs for prototyping, characterization, and scale-up testing. Large testbeds and pilot facilities let partners validate systems under realistic conditions, while corporate engagement teams streamline sponsored research and talent pipelines. Faculty win competitive federal funding from agencies such as the National Science Foundation, National Institutes of Health, the Department of Energy, and the Department of Defense. Technology transfer supports IP, licensing, and startup formation via industry-friendly agreements.